SE429971B - Forfarande for framstellning av 1alfa-hydroxylerade foreningar - Google Patents

Forfarande for framstellning av 1alfa-hydroxylerade foreningar

Info

Publication number
SE429971B
SE429971B SE7907631A SE7907631A SE429971B SE 429971 B SE429971 B SE 429971B SE 7907631 A SE7907631 A SE 7907631A SE 7907631 A SE7907631 A SE 7907631A SE 429971 B SE429971 B SE 429971B
Authority
SE
Sweden
Prior art keywords
ether
lower alkyl
solution
acyl
vitamin
Prior art date
Application number
SE7907631A
Other languages
English (en)
Swedish (sv)
Other versions
SE7907631L (sv
Inventor
Luca H F De
H K Schnoes
D E Hamer
H E Paaren
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of SE7907631L publication Critical patent/SE7907631L/xx
Publication of SE429971B publication Critical patent/SE429971B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
SE7907631A 1978-01-16 1979-09-13 Forfarande for framstellning av 1alfa-hydroxylerade foreningar SE429971B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86944878A 1978-01-16 1978-01-16
US05/914,796 US4195027A (en) 1978-01-16 1978-06-12 Process for preparing 1α-hydroxylated compounds

Publications (2)

Publication Number Publication Date
SE7907631L SE7907631L (sv) 1979-09-13
SE429971B true SE429971B (sv) 1983-10-10

Family

ID=27128114

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7907631A SE429971B (sv) 1978-01-16 1979-09-13 Forfarande for framstellning av 1alfa-hydroxylerade foreningar

Country Status (15)

Country Link
US (1) US4195027A (ro)
JP (1) JPS5828876B2 (ro)
AU (1) AU525781B2 (ro)
BE (1) BE873512A (ro)
CA (1) CA1156251A (ro)
CH (2) CH658050A5 (ro)
DE (2) DE2933189T1 (ro)
DK (3) DK147912C (ro)
FR (4) FR2438035A1 (ro)
GB (1) GB2013686B (ro)
IE (1) IE48547B1 (ro)
NL (1) NL188901C (ro)
NZ (1) NZ189388A (ro)
SE (1) SE429971B (ro)
WO (1) WO1979000513A1 (ro)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16989A (en) * 1978-11-07 1984-05-04 Res Inst Medicine Chem Process for the preparation of 1-hydroxylated vitamin d compounds
US4269777A (en) * 1979-05-21 1981-05-26 Wisconsin Alumni Research Foundation Isotopically labeled vitamin D derivatives and processes for preparing same
JPS5626820A (en) * 1979-08-10 1981-03-16 Chugai Pharmaceut Co Ltd Immunosuppressing agent
US4265822A (en) * 1979-09-10 1981-05-05 Wisconsin Alumni Research Foundation Process for preparing 1-hydroxylated vitamin D compounds from 5,6-trans-vitamin D compounds
US4297289A (en) * 1980-07-17 1981-10-27 Wisconsin Alumni Research Foundation Vitamin D compounds isotopically substituted at carbon 6 and process for their preparation
DE3270978D1 (en) * 1981-07-17 1986-06-12 Duphar Int Res Method of preparing 1-alpha-hydroxyvitamin d and 1-alpha-hydroxy-previtamin d compounds, and adduct of a previtamin d or tachysterol compound with a suitable dienophile
US4617297A (en) * 1982-02-12 1986-10-14 Hoffmann-La Roche Inc. Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
IE58277B1 (en) * 1983-05-09 1993-08-25 Wisconsin Alumni Res Found 1 , 25-dihydroxylated vitamin d2 compounds and intermediates in the preparation thereof
AU584071B2 (en) * 1984-03-05 1989-05-18 Wisconsin Alumni Research Foundation 1a-hydroxyvitamin d2 analogs and process for preparing same
US4555364A (en) * 1984-11-01 1985-11-26 Wisconsin Alumni Research Foundation Method for preparing 1-hydroxyvitamin D compounds
WO1987000834A1 (en) * 1985-08-02 1987-02-12 Leo Pharmaceutical Products Ltd. A/S Novel vitamin d analogues
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5869473A (en) * 1988-08-02 1999-02-09 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US5321018A (en) * 1989-03-09 1994-06-14 Wisconsin Alumni Research Foundation Use of 1α-hydroxylated-19-nor-vitamin D compounds to treat psoriasis
JP2645130B2 (ja) * 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
US5401731A (en) * 1989-06-29 1995-03-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) Vitamin D analogues
US5532228A (en) * 1990-02-06 1996-07-02 Schering Aktiengesellschaft Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
US5798345A (en) * 1990-09-21 1998-08-25 Bone Care International, Inc. Method of inhibiting the hyperproliferation of malignant cells
US6025346A (en) * 1990-09-21 2000-02-15 Bone Care International, Inc. 1α-hydroxy vitamin D4 and novel intermediates and analogues
CA2069084C (en) * 1990-09-21 2007-05-22 Joyce C. Knutson 1.alpha.-hydroxy vitamin d4 and novel intermediates and analogues
US5763428A (en) * 1990-09-21 1998-06-09 Bone Care International, Inc. Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
US5801164A (en) * 1990-09-21 1998-09-01 Bone Care International, Inc. Methods of treating osteoporosis prophylactically or therapeutically
US5786348A (en) * 1991-01-08 1998-07-28 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6166000A (en) * 1991-01-08 2000-12-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-Dihydroxy vitamin . D.sub2
EP0550702B1 (en) * 1991-01-08 1999-05-06 Bone Care International, Inc. METHODS FOR PREPARATION AND USE OF 1$g(a),24-DIHYDROXY VITAMIN D 2?
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US6251883B1 (en) 1991-01-08 2001-06-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
JP3179495B2 (ja) * 1992-08-28 2001-06-25 ボーン ケア インターナショナル インコーポレイテッド １α，２４（Ｓ）−ジヒドロキシビタミンＤ▲下２▼の調製及び使用方法
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US5869472A (en) * 1994-07-18 1999-02-09 Bone Care International, Inc. Synthesis of 1α-hydroxy vitamin D
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6242434B1 (en) 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
WO1997011053A1 (en) * 1995-09-21 1997-03-27 Wisconsin Alumni Research Foundation Calcitriol derivatives and their uses
US5952317A (en) * 1995-09-21 1999-09-14 Wisconsin Alumni Research Foundation Calcitriol derivatives and their uses
US5976784A (en) * 1996-09-20 1999-11-02 Wisconsin Alumni Research Foundation Calcitriol derivatives and their uses
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
NZ336924A (en) * 1997-02-13 2001-06-29 Bone Care Int Inc Targeted therapeutic delivery of vitamin D compounds via a Vitamin D conjugate
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
CA2326117A1 (en) * 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
US5972917A (en) * 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
WO2002006218A2 (en) * 2000-07-18 2002-01-24 Bone Care International, Inc. STABILIZED 1α-HYDROXY VITAMIN D
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20050239756A1 (en) * 2004-04-23 2005-10-27 Bone Care International, Inc. Methods of treating various vitamin D metabolism conditions with 1alpha-hydroxyvitamin D2
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7491712B1 (en) * 2007-12-10 2009-02-17 Formosa Laboratories, Inc. Process for preparation of paricalcitol and intermediates thereof
EP2334640B1 (en) * 2008-07-22 2015-12-23 Azad Pharmaceutical Ingredients AG Methods for producing paricalcitol
US20120184514A1 (en) * 2009-07-01 2012-07-19 Vitamin Derivatives Inc. Vitamin d compounds and methods for preparing same
CN114805158B (zh) * 2022-04-24 2023-11-14 浙江花园生物医药股份有限公司 一种制备骨化三醇的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901928A (en) * 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US3847955A (en) * 1973-07-16 1974-11-12 Wisconsin Alumni Res Found 1,24,25-trihydroxycholecalciferol
CA1034114A (en) * 1973-12-03 1978-07-04 Wisconsin Alumni Research Foundation Processes for preparation of steroid derivatives
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US3907843A (en) * 1974-06-14 1975-09-23 Wisconsin Alumni Res Found 1{60 -Hydroxyergocalciferol and processes for preparing same
US3976636A (en) * 1974-10-10 1976-08-24 The Upjohn Company Process and compounds

Also Published As

Publication number Publication date
NL188901C (nl) 1992-11-02
FR2438035B1 (ro) 1984-02-24
GB2013686A (en) 1979-08-15
JPS5828876B2 (ja) 1983-06-18
AU4339479A (en) 1979-07-26
CH658050A5 (de) 1986-10-15
BE873512A (fr) 1979-05-16
FR2478631B1 (ro) 1984-02-24
DK169871B1 (da) 1995-03-20
DK374083A (da) 1983-08-16
DK147912B (da) 1985-01-07
IE790055L (en) 1979-07-16
US4195027A (en) 1980-03-25
DK170437B1 (da) 1995-09-04
FR2478631A1 (fr) 1981-09-25
DE2933189C2 (ro) 1991-05-29
NZ189388A (en) 1981-02-11
WO1979000513A1 (en) 1979-08-09
FR2529888A1 (fr) 1984-01-13
NL7900331A (nl) 1979-07-18
DE2954557C2 (ro) 1991-07-11
JPS54500080A (ro) 1979-11-29
SE7907631L (sv) 1979-09-13
NL188901B (nl) 1992-06-01
FR2529888B1 (fr) 1986-04-04
CH653321A5 (de) 1985-12-31
DK374083D0 (da) 1983-08-16
CA1156251A (en) 1983-11-01
FR2438035A1 (fr) 1980-04-30
DK436182A (da) 1982-10-01
FR2436140A1 (fr) 1980-04-11
DE2933189T1 (de) 1980-12-18
DK365079A (da) 1979-08-31
AU525781B2 (en) 1982-12-02
GB2013686B (en) 1982-04-15
IE48547B1 (en) 1985-03-06
DK147912C (da) 1985-06-17

Similar Documents

Publication Publication Date Title
SE429971B (sv) Forfarande for framstellning av 1alfa-hydroxylerade foreningar
US4202829A (en) Process for preparing 1α-hydroxylated compounds
US4260549A (en) Process for preparing 1α-hydroxylated compounds
US4338250A (en) 1-Hydroxylation process
US5414098A (en) Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
JPH0518839B2 (ro)
GB2026494A (en) Fluorinated compounds of the vitamin d structure
IE50425B1 (en) Vitamin d derivatives
Aberhart et al. Studies on the adduct of 4-phenyl-1, 2, 4-triazoline-3, 5-dione with vitamin D3
US5030772A (en) Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
Paaren et al. Direct C-1 hydroxylation of vitamin D compounds: convenient preparation of 1alpha-hydroxyvitamin D3, 1alpha, 25-dihydroxyvitamin D3, and 1alpha-hydroxyvitamin D2.
CA1254225A (en) PROCESS FOR PREPARING 1.alpha.-HYDROXYLATED COMPOUNDS
JPS5945674B2 (ja) １α−ヒドロキシシクロビタミンＤ誘導体
US4263214A (en) Fluorovitamin D compounds and processes for their preparation
SAI et al. Synthesis and biological activity of 1α-hydroxy-24, 24-dimethyl-22E-dehydrovitamin D3 and 1α, 25-dihydroxy-24, 24-dimethyl-22E-dehydrovitamin D3
US4260804A (en) Processes for preparing calcitroic acid and esters thereof
WO1980002502A1 (en) 1 alpha -hydroxy-25-keto-27-nor-cholecalciferol and processes for preparing same
Paaren et al. Preparation of tritium-or deuterium-labeled vitamin D analogs by a convenient general method
US4230627A (en) Fluorovitamin D compounds and processes for their preparation
IL97163A (en) Preparation of appropriate vitamin D2 compounds and A-hydroxy history
DeLuca et al. 1, 25-dihydroxyvitamin D 2 compounds
IE51714B1 (en) 5,7-diene intermediates useful in preparing calcitroic acid and esters thereof
JPH04211052A (ja) ビタミンＤ２　化合物及び対応の１α−ヒドロキシル化誘導体の製造方法

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7907631-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7907631-1

Format of ref document f/p: F